NYSE:BAX
Baxter International Inc (BAX)
19.38
+0.03 (0.16%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
11 watching
Financials 
Technical Analysis 0
TOP PICK
Global healthcare. Products tend to target blood and circulatory problems. Most of their products tend to be used in critical/chronic care situations so not affected by the economy. About 60% of earnings come from outside the US. Think they have a strong pipeline going forward.
Christine PooleOwned
biotechnologypharmaceutical
TOP PICK
Global healthcare. Products tend to target blood and circulatory problems. Most of their products tend to be used in critical/chronic care situations so not affected by the economy. About 60% of earnings come from outside the US. Think they have a strong pipeline going forward.
Christine PooleOwned
biotechnologypharmaceutical
TOP PICK
This group has been out of favour since 2000. This one has an above average growth rate against its peers. Have 3 core areas and all 3 are doing very well. Margins are expanding. Estimates are rising. International exposure.
David BurrowsOwned
biotechnologypharmaceutical
Showing 31 to 35 of 35 entries
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
